Home › Funds › EQT Fund Management S.a r.l. › OCS
EQT Fund Management S.a r.l. position in OCS
Oculis Holding AG · Health Care
EQT Fund Management S.a r.l. reported holding 6,950,294 shares of OCS (Oculis Holding AG) in its Q3 2026 13F filing — a position valued at US$64.9M, representing 6.85% of its reported portfolio and ranking #3 among its reported holdings. EQT Fund Management S.a r.l. has disclosed OCS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How EQT Fund Management S.a r.l.'s OCS position evolved
EQT Fund Management S.a r.l. first disclosed a stake in OCS in Q3 2025 at 5,900,294 shares (US$103.7M). The position peaked in Q1 2026 at 5,900,294 shares, worth US$156.9M. Across 5 filings, EQT Fund Management S.a r.l. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 6,950,294 shares valued at US$64.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 5.90M | $103.73M | New |
| Q4 2025 | 5.90M | $117.83M | Hold |
| Q1 2026 | 5.90M | $156.89M | Hold |
| Q2 2026 | 6.95M | $96.40M | Add |
| Q3 2026 | 6.95M | $64.92M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OCS and 13F data
OCS (Oculis Holding AG) is a Health Care company. 64 other funds we track also report a position in OCS — the largest reported positions include Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M), Saturn V Capital Management LP (US$9.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OCS
- Gildi - lifeyrissjodur 2.43M sh · $64.32M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.51M sh · $20.89M · Q2 2026
- Saturn V Capital Management LP 684.88K sh · $9.50M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 641.02K sh · $8.89M · Q2 2026
- SYQUANT CAPITAL SAS 375.00K sh · $5.20M · Q2 2026
- Nan Fung Group Holdings Ltd 300.56K sh · $4.17M · Q2 2026
- Marble Bar Asset Management LLP 14.81K sh · $205.36K · Q2 2026
- DUPONT CAPITAL MANAGEMENT CORP 4 sh · $55.00K · Q2 2026
More on EQT Fund Management S.a r.l.
FAQ
How long has EQT Fund Management S.a r.l. held OCS?
EQT Fund Management S.a r.l. has disclosed OCS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is EQT Fund Management S.a r.l.'s current position in OCS?
As of Q3 2026, EQT Fund Management S.a r.l. holds 6.95M shares of OCS (Oculis Holding AG), valued at $64.92M, representing 6.85% of its reported portfolio and ranking #3.
Has EQT Fund Management S.a r.l. been buying or selling OCS?
In the latest 13F filing (Q3 2026), EQT Fund Management S.a r.l. held unchanged its position in OCS. The position peaked in Q1 2026 at 5.90M shares.
Which other funds hold OCS?
Other major institutional holders of OCS include Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, Saturn V Capital Management LP, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.